"Prostate cancer metastasis" trang 1 - tải miễn phí từ tailieunhanh
Prostate cancer solitary metastasis to anal canal: Case report and review of literature

Prostate cancer solitary metastasis to anal canal: Case report and review of literature
6    50    0
Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82

Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82
17    39    1
Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial
8    19    1
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223
19    50    1
Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis
9    45    1
The role of S100A4 for bone metastasis in prostate cancer cells

The role of S100A4 for bone metastasis in prostate cancer cells
13    22    1
Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
7    28    1
The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: Effects of radiation dose escalation

The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: Effects of radiation dose escalation
8    33    1
SPARKLE: A new spark in treating oligorecurrent prostate cancer: Adding systemic treatment to stereotactic body radiotherapy or metastasectomy: Key to long-lasting event-free survival?

SPARKLE: A new spark in treating oligorecurrent prostate cancer: Adding systemic treatment to stereotactic body radiotherapy or metastasectomy: Key to long-lasting event-free survival?
10    11    1
An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: Case report and literature review

An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: Case report and literature review
5    76    0
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
9    97    0
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: Prospects for personalized medicine

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: Prospects for personalized medicine
15    7    1
Usefulness of combined androgen blockade therapy with gonadotropinreleasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL

Usefulness of combined androgen blockade therapy with gonadotropinreleasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL
11    75    1
Prognostic factors for overall survival in patients with spinal metastasis secondary to prostate cancer: A systematic review and meta-analysis

Prognostic factors for overall survival in patients with spinal metastasis secondary to prostate cancer: A systematic review and meta-analysis
12    25    1
SFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis

SFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis
11    26    1
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
10    45    1
Metastasis-directed therapy in castrationrefractory prostate cancer (MEDCARE): A non-randomized phase 2 trial

Metastasis-directed therapy in castrationrefractory prostate cancer (MEDCARE): A non-randomized phase 2 trial
7    52    0
Systemic and tumor-directed therapy for oligometastatic prostate cancer: Study protocol for a phase II trial for veterans with de novo oligometastatic disease

Systemic and tumor-directed therapy for oligometastatic prostate cancer: Study protocol for a phase II trial for veterans with de novo oligometastatic disease
6    34    1
Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer

Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer
15    46    1
Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells

Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells
12    35    1